Hybrid-Actuating Macrophage-Based Microrobots for Active Cancer Therapy

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Han, Jiwon ^a   Zhen, Jin ^a   Du Nguyen, Van ^a   Go, Gwangjun ^a   Choi, Youngjin ^a   Ko, Seong Young ^a   Park, Jong Oh ^a   Park, Sukho ^a  

^a Chonnam National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

MAGNETITE NANOPARTICLE;

ANIMAL; BIOLOGICAL THERAPY; EXPERIMENTAL NEOPLASM; IMMUNOLOGY; MACROPHAGE; MOUSE; MULTICELLULAR SPHEROID; PATHOLOGY; PROCEDURES; ROBOTICS; THERANOSTIC NANOMEDICINE; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CELL- AND TISSUE-BASED THERAPY; MACROPHAGES; MAGNETITE NANOPARTICLES; MICE; NEOPLASMS, EXPERIMENTAL; ROBOTICS; SPHEROIDS, CELLULAR; THERANOSTIC NANOMEDICINE;

EID: 84977104416     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep28717     Document Type: Article

References (47)

1. Kobayashi, H., Watanabe, R. & Choyke, P. L. Improving conventional enhanced permeability and retention (EPR) effects; what is the appropriate target? Theranostics 4, 81-89 (2014).
2. Alexis, F., Pridgen, E., Molnar, L. K. & Farokhzad, O. C. Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol. Pharm. 5, 505-515 (2008).
3. Fang, J., Nakamura, H. & Maeda, H. The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv. Drug. Deliv. Rev. 18, 136-151 (2011).
4. Maki, S., Konno & Maeda, T. H. Image enhancement in computerized tomography for sensitive diagnosis of liver cancer and semiquantitation of tumor selective drug targeting with oily contrast medium. Cancer 56, 751-757 (1985).
5. Nagamitsu, A., Greish, K. & Maeda, H. Elevating blood pressure as a strategy to increase tumor-Targeted delivery of macromolecular drug SMANCS: cases of advanced solid tumors. Jpn. J. Oncol. 39, 756-766 (2009).
6. Madsen, S. J., Baek, S. K., Makkouk, A. R., Krasieva, T. & Hirschberg, H. Macrophages as cell-based delivery systems for nanoshells in photothermal therapy. Ann. Biomed. Eng. 40, 507-515 (2012).
7. Ross, J. A. & Auger, M. J. The biology of the macrophage. In: Burke, B., Lewis, C. E. (Eds), The Macrophage, 2nd edition. Oxford University Press, Oxford, 1-72 (2002).
8. Choi, M. R. et al. A cellular Trojan Horse for delivery of therapeutic nanoparticles into tumors. Nano. Lett. 7, 3759-3765 (2007).
9. Kelly, P. M. A., Davison, R. S., Bliss, E. & McGee, J. O. Macrophages in human breast disease: A quantitative immunohistochemical study. Br. J. Cancer 57, 174-177 (1988).
10. Frantz, S. & Nahrendorf, M. Cardiac macrophages and their role in ischaemic heart disease. Cardiovasc. Res. 102, 240-248 (2014).
11. Tripathi, C. et al. Macrophages are recruited to hypoxic tumor areas and acquire a pro-Angiogenic M2-polarized phenotype via hypoxic cancer cell derived cytokines Oncostatin M and Eotaxin. Oncotarget. 30, 5350-6538 (2014).
12. Zhang, B. C. et al. Tumor-Associated macrophages infiltration is associated with peritumoral lymphangiogenesis and poor prognosis in lung adenocarcinoma. Med. Oncol. 28, 1447-1452 (2011).
13. Negus, R. P. M., Stamp, G. W. H., Hadley, J. & Balkwill, F. R. Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines. Am. J. Pathol. 150, 1723-1734 (1997).
14. Movahedi, K. et al. Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C (high) monocytes. Cancer Res. 70, 5728-5739 (2010).
15. Cortez-Retamozo, V. et al. Origins of tumor-Associated macrophages and neutrophils. Proc. Natl.Acad. Sci. USA 109, 2491-2496 (2012).
16. Muthana, M. et al. Directing cell therapy to anatomic target sites in vivo with magnetic resonance targeting. Nat. Commun. doi: 10.1038/ncomms9009 (2015).
17. Shen, S. et al. Preliminary design towards a magnetic actuated drug delivery system. IEEE 7th International conference on CIS&RAM, pp. 245-249 (2015).
18. Krishnamachari, Y., Geary, S. M., Lemke, C. D. & Salem, A. K. Nanoparticle delivery systems in cancer vaccines. Pharm. Res. 28, 215-236 (2011).
19. Gupta, R. K., Chang, A. C. & Siber, G. R. Biodegradable polymer microspheres as vaccine adjuvants and delivery systems. Dev. Biol. Stand. 92, 63-78 (1998).
20. Hedley, M. L., Curley, J. & Urban, R. Microspheres containing plasmid-encoded antigens elicit cytotoxic T-cell responses. Nat. Med. 4, 365-368 (1998).
21. Helson, R. et al. Polylactide-co-glycolide (PLG) microparticles modify the immune response to DNA vaccination. Vaccine 26, 753-761 (2008).
22. Kovacsovics-Bankowski, M. & Rock, K. L. A phagosome-To-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science 267, 243-246 (1995).
23. Ankrum, J. A. et al. Engineering cells with intracellular agent-loaded microparticles to control cell phenotype. Nat. Protoc. 9, 233-245 (2014).
24. Thorek, D. L. & Tsourkas, A. Size, charge and concentration dependent uptake of iron oxide particles by non-phagocytic cells. Biomaterials 29, 3583-3590 (2008).
25. Park, S. J. et al. Monocyte-based microrobot with chemotactic motility for tumor theragnosis. Biotechnol. Bioeng. 111, 2132-2138 (2014).
26. Sun, J. et al. Synthesis and characterization of biocompatible Fe3O4 nanoparticles. J. Biomed. Mater. Res. A. 80, 333-341 (2007).
27. Keum, C. G. et al. Practical preparation procedures for docetaxel-loaded nanoparticles using polylactic acid-co-glycolic acid. Int. J. Nanomedicine 6, 2225-2234 (2011).
28. Park, S. J. et al. New paradigm for tumor theranostic methodology using bacteria-based microrobot. Sci. Rep. 3, 3394-3401 (2013).
29. Panyam, J. & Labhasetwar, V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv. Drug Deliv. Rev. 55, 329-347 (2003).
30. Panyam, J., Zhou, W.-Z., Prabha, S., Sahoo, S. K. & Labhasetwar, V. Rapid endo-lysosomal escape of poly (DL-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery. FASEB J. 16, 1217-1226 (2002).
31. Patil, Y., Sadhukha, T., Ma, L. & Panyam, J. Nanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistance. J. Control Release 136, 21-29 (2009).
32. Acharya, S. & Sahoo, S. K. PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect. Adv. Drug Deliv. Rev. 63, 170-183 (2011).
33. Chertok, B. et al. Iron Oxide Nanoparticles as a Drug Delivery Vehicle for MRI Monitored Magnetic Targeting of Brain Tumors. Biomaterials 29, 487-496 (2008).
34. Vandergriff, A. C. et al. Magnetic targeting of cardiosphere-derived stem cells with ferumoxytol nanoparticles for treating rats with myocardial infarction. Biomaterials 35, 8528-8539 (2014).
35. Kodama, A. et al. In vivo bioluminescence imaging of transplanted bone marrow mesenchymal stromal cells using a magnetic delivery system in a rat fracture model. J. Bone Joint Surg. Br. 94, 998-1006 (2012).
36. Vanecek, V. et al. Highly efficient magnetic targeting of mesenchymal stem cells in spinal cord injury. Int. J. Nanomedicine 7, 3719-3730 (2012).
37. Dormer, K. J. et al. Magnetically-Targeted, technetium 99 m-labeled nanoparticles to the inner ear. J. Biomed. Nanotech. 4, 1-11 (2008).
38. Connell, J. J., Patrick, P. S., Yu, Y., Lythgoe, M. F. & Kalber, T. L. Advanced cell therapies: Targeting, tracking and actuation of cells with magnetic particles. Regen. Med. 10, 757-772 (2015).
39. Consigny, P. M., Silverberg, D. A. & Vitali, N. J. Use of endothelial cells containing superparamagnetic microspheres to improve endothelial cell delivery to arterial surfaces after angioplasty. J. Vasc. Interv. Radiol. 10, 155-163 (1999).
40. Arbab, A. S. et al. In vivo trafficking and targeted delivery of magnetically labeled stem cells. Hum. Gene Ther. 15, 351-360 (2004).
41. Riegler. J. et al. Targeted magnetic delivery and tracking of cells using a magnetic resonance imaging system. Biomaterials 31, 5366-5371 (2010).
42. Riegler, J. et al. Superparamagnetic iron oxide nanoparticle targeting of MSCs in vascular injury. Biomaterials 34, 1987-1994 (2013).
43. Riegler, J., Allain, B., Cook, R. J., Lythgoe, M. F. & Pankhurst, Q. A. Magnetically assisted delivery of cells using a magnetic resonance imaging system. J. Phys. D Appl. Phys. 44, 055001 (2011).
44. Choi, H., Choi, J., Jang, G., Park, J. O. & Park, S. Two-dimensional actuation of a microrobot with a stationary two-pair coil system. Smart Mater. Struct. 18, 055007 (2009).
45. Choi, H. et al. Two-dimensional locomotion of a microrobot with a novel stationary electromagnetic actuation system. Smart Mater. Struct. 18, 115017 (2009).
46. Muthu, M. S., Kulkarni, S. A., Raju, A. & Feng, S. S. Theranostic liposomes of TPGS coating for targeted co-delivery of docetaxel and quantum dots. Biomaterials 33, 3494-3501 (2012).
47. Muthu, M. S., Kulkarni, S. A., J. Xiong, J. & Feng, S. S. Vitamin E TPGS coated liposomes enhanced cellular uptake and cytotoxicity of docetaxel in brain cancer cells. Int. J. Pharm. 421, 332-340 (2011).